Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$689M |
| 2 |
NVIDIA
NVDA
|
+$475M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
+$350M |
| 4 |
Microsoft
MSFT
|
+$347M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$262M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$185M |
| 2 |
Meta Platforms (Facebook)
META
|
+$131M |
| 3 |
Arm
ARM
|
+$91.4M |
| 4 |
CRH
CRH
|
+$78.5M |
| 5 |
Unity
U
|
+$69.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.11% |
| 2 | Industrials | 9.48% |
| 3 | Financials | 7.56% |
| 4 | Consumer Discretionary | 5.65% |
| 5 | Healthcare | 4.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Charter Communications
CHTR
$17.9B
| $3.04M | 0.01% |
21,399
+19,190
| +869% | +$3.2M |
|
852
NewAmsterdam Pharma
NAMS
$3.33B
| $3.04M | 0.01% |
+89,765
| New | +$2.96M |
|
853
Zebra Technologies
ZBRA
$17.4B
| $3.03M | 0.01% |
11,521
+8,322
| +260% | +$1.96M |
|
854
CALL
KLA
KLAC
$240B
| $3.02M | 0.01% |
10,000
-20,000
| -67% | -$3.97M |
|
|
855
PUT
KLA
KLAC
$240B
| $3.02M | 0.01% |
+10,000
| New | +$1.99M |
|
856
IonQ
IONQ
$18.2B
| $3.01M | 0.01% |
56,606
-23,877
| -30% | -$1.21M |
|
|
EQPT
857
EquipmentShare.com Inc
EQPT
$4.69B
| $3.01M | 0.01% |
153,167
-63,387
| -29% | -$1.36M |
|
858
Blackstone Secured Lending
BXSL
$5.77B
| $3M | 0.01% |
+126,726
| New | +$3.03M |
|
|
LTGRU
859
Long Table Growth Corp Units
LTGRU
$150M
| $3M | 0.01% |
+300,000
| New | +$3.01M |
|
860
Elevance Health
ELV
$86.9B
| $3M | 0.01% |
7,764
-76,113
| -91% | -$28.2M |
|
861
Dyne Therapeutics
DYN
$4.87B
| $2.99M | 0.01% |
+134,752
| New | +$2.51M |
|
862
Petrobras Class A
PBR.A
$111B
| $2.98M | 0.01% |
+203,429
| New | +$3.59M |
|
|
ARCI
863
Archimedes Tech SPAC Partners III
ARCI
$358M
| $2.98M | 0.01% |
+297,404
| New | +$2.95M |
|
864
Hilton Grand Vacations
HGV
$3.51B
| $2.97M | 0.01% |
56,753
+48,586
| +595% | +$2.34M |
|
865
Regeneron Pharmaceuticals
REGN
$85.9B
| $2.97M | 0.01% |
+4,759
| New | +$3.24M |
|
|
SLN
866
Silence Therapeutics
SLN
$825M
| $2.96M | 0.01% |
+269,348
| New | +$1.89M |
|
867
CALL
VanEck Semiconductor ETF
SMH
$68.6B
| $2.95M | 0.01% |
+4,500
| New | +$2.46M |
|
868
Charles River Laboratories
CRL
$14.1B
| $2.95M | 0.01% |
13,005
-39,954
| -75% | -$7.11M |
|
869
Coherent
COHR
$56.7B
| $2.94M | 0.01% |
7,449
-17,655
| -70% | -$6.24M |
|
870
CALL
Transocean
RIG
$6.61B
| $2.93M | 0.01% |
600,000
| – | – |
|
871
TKO Group
TKO
$14.1B
| $2.93M | 0.01% |
+14,544
| New | +$2.84M |
|
872
Procept Biorobotics
PRCT
$1.24B
| $2.93M | 0.01% |
129,660
+81,847
| +171% | +$2.05M |
|
|
KRAQ
873
KRAKacquisition Corp
KRAQ
$431M
| $2.92M | 0.01% |
+291,940
| New | +$2.9M |
|
|
EVAC
874
EQV Ventures Acquisition Corp II
EVAC
$600M
| $2.9M | 0.01% |
285,000
+115,717
| +68% | +$1.17M |
|
|
DRDB
875
Roman DBDR Acquisition Corp II
DRDB
$326M
| $2.9M | 0.01% |
275,159
+8,477
| +3% | +$89.2K |
|
Similar funds
Steve Schonfeld's Q2 2026 Portfolio in Review
As of Q2 2026, Steve Schonfeld held 3,207 positions worth $27.9B, up 96% from $14.2B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Steve Schonfeld deployed $11.3B of net new capital in Q2 2026, opening 1,059 new positions and adding to 750 existing holdings. Its largest new stake was iShares MSCI Brazil ETF: 9,366,387 shares worth $323M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $185M trimmed.
- Steve Schonfeld's largest Q2 2026 buy was iShares MSCI Brazil ETF: 9,366,387 shares worth $323M.
- Steve Schonfeld added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $689M increase.
- Steve Schonfeld's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $185M.
- Steve Schonfeld fully exited Marvell Technology in Q2 2026, selling an estimated $60.3M.
- Steve Schonfeld's ten largest holdings make up 29% of its $27.9B portfolio in Q2 2026.
- Steve Schonfeld opened 1,059 new positions and closed 651 in Q2 2026.
- Steve Schonfeld's portfolio value rose 96% quarter-over-quarter to $27.9B.
Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.